참고문헌
- Schwartz GJ, Mehta RH, Wenig BL, et al : Salvage management for recurrent squamous cell carcinoma of the oral cavity. Head Neck 22 : 34, 2000 https://doi.org/10.1002/(SICI)1097-0347(200001)22:1<34::AID-HED6>3.0.CO;2-3
- Schrijvers D, Johnson J, Jiminez U, et al : Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study group. J Clin Oncol 16 : 1054, 1998
- Cusack JC, Jr, Tanabe KK : Cancer gene therapy. Surg Oncol Clin N Am 7 : 421, 1998
- Xi S, Grandis JR : Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82 : 11, 2003 https://doi.org/10.1177/154405910308200104
- Anderson MJ, Stanbridge EJ : Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J 7 : 826, 1993
- Cai DW, Mukhopadhyay T, Liu Y, et al : Stable expression of the wild-type p53 gene in humna lung cancer after retrovirus-mediated gene transfer. Hum Gene Ther 4 : 617, 1993 https://doi.org/10.1089/hum.1993.4.5-617
- Wang J, Bucana CD, Roth JA, et al : Apoptosis induced in human osteosarcoma cells is one of the mechanims for the cytocidal effect of Ad5CMV-p53. Cancer Gene Ther 2 : 9, 1995
- Liu TJ, Zhang WW, Taylor DL, et al : Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54 : 3662, 1994
- Zhang WW, Fang X, Mazur W, et al : High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1 : 5, 1994
- Kim TE, Kim YW, Kim JW et al : Candidate tumor suppressor, HCCS-1, is downregulated in human cancers and induces apoptosis in cervical cancer. Int J Cancer 97 : 780, 2002 https://doi.org/10.1002/ijc.10124
- Rheinwald JG, Beckett MA : Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41 : 1657, 1981
- He TC, Zhou S, DaCosta LT, et al : Simplified system for generating recombinant adenovirus. Proc Natl Acad Sci 95 : 2509, 1998
- Takenouchi, T, Munetaka E : Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci 56 : 479, 1995 https://doi.org/10.1016/0024-3205(95)00235-X
- Wolff JA, Trubetskoy VS : The Cambrian period of nonviral gene delivery (news). Nat Biotechnol 16 : 421, 1998 https://doi.org/10.1038/nbt0598-421
- Robbins PD, Tahara H, Ghivizzani SC : Viral vectors for gene therapy. Trends Biotechnol 16 : 35, 1998 https://doi.org/10.1016/S0167-7799(97)01137-2
- McGroy WJ, Bautista DS, Graham FL : A simple techniques for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 163 : 614, 1988 https://doi.org/10.1016/0042-6822(88)90302-9
- Graham FL, Smiley J : Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36 : 59, 1977 https://doi.org/10.1099/0022-1317-36-1-59
- Daqing L, Ling D, Paul F, et al : Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res 5 : 4175, 1999
- Zhang WW : Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 6 : 113, 1999 https://doi.org/10.1038/sj.cgt.7700024
- Chirmule N, Propert K, Magosin S, et al : Immune responses to adenovirus and adeno-associated virus in humans. Cancer Gene Ther 6 : 1574, 1999
- Hamada K, Sakaue M, Alemany R, et al : Adenovirus transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gyne Oncol 63 : 219, 1996 https://doi.org/10.1006/gyno.1996.0310
- Cho SD, Hwang SJ, Park HR, et al. Development of gene therapy strategy using plasmid and adenovirus in cervical cancer treatment. J Kor Obstet Gynecol 42: 2019, 1999
- Kim MS, Kwon HC, Hong SI, et al : Adenovirus-mediated gene transfer of wild-type p53 results in restoration of tumor suppressor gene function in glioma cell line. J Kor Cancer Assoc20: 1026, 1998
- Clayman GL, Frank DK, Bruso PA, et al : Adenovirusmediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin Cancer Res 5 : 1715, 1999
- Sun LM, Leung SW, Su CY : The relapse patterns and outcome of postoperative recurrent tongue cancer. J Oral Maxillofac Surg 55 : 827, 1997 https://doi.org/10.1016/S0278-2391(97)90342-6
- Shillitoe EJ : Gene therapy for head and neck cancer. Oral Oncol 34 : 157, 1998 https://doi.org/10.1016/S1368-8375(98)00002-5
- Shillitoe EJ, Laypeyre JN, Adler-Storthz K : Gene therapy-it's potential in the management of oral cancer. Oral Oncol 3 : 957, 1996
- Kim TE, Ro DY, Kim YW, et al. Adenovirus-mediated thymidine kinase gene trasnfer with exposure of ganciclovir to uterine cervical cancer cell. Kor J Gynecol Oncol Colposcopy 14: 195, 2003
- Nemunaitis J, Ganly I, Khuri F, et al : Seletive replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer; a phase II trial. Cancer Res 60 : 6359, 2000
- Fukuhara H, Hayashi Y, Yamamoto N, et al. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell line. Oral Oncol 39 : 601, 2003 https://doi.org/10.1016/S1368-8375(03)00047-2